These observations, although not conclusive, suggest that the in vivo application of this system should be tested, since DNA demethylation of THOR may affect self-renewal potential of cancer cells, as well as other cancer pathways, thus constituting a potential therapeutic target for BC. The gene discussed is THORLNC; the disease is breast cancer.